Cargando…

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510733/ https://www.ncbi.nlm.nih.gov/pubmed/37736329 http://dx.doi.org/10.2147/DMSO.S439882

Ejemplares similares

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice
por: Niu, Shu, et al.
Publicado: (2023)

Corrigendum: Vegetarian diet, food substitution, and nonalcoholic fatty liver
Publicado: (2018)

Corrigendum to “Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease”
por: Masarone, Mario, et al.
Publicado: (2021)

Corrigendum to “The Effect of a Hydrolyzed Polysaccharide Dietary Supplement on Biomarkers in Adults with Nonalcoholic Fatty Liver Disease”
por: Lewis, John E., et al.
Publicado: (2020)

Corrigendum to “Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives”
por: Gitt, Stefano, et al.
Publicado: (2020)

Corrigendum to: Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled
Publicado: (2022)

Corrigendum to “Caffeoylquinic Acid-Rich Extract of Aster glehni F. Schmidt Ameliorates Nonalcoholic Fatty Liver through the Regulation of PPARδ and Adiponectin in ApoE KO Mice”
por: Lee, Yong-Jik, et al.
Publicado: (2019)

Corrigendum to “Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp”
por: Mahamid, Mahmud, et al.
Publicado: (2017)

S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Corrigendum]
Publicado: (2013)

Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy [Corrigendum]
Publicado: (2021)

Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease
por: Ma, Yuting, et al.
Publicado: (2021)

Corrigenda: Table Correction. Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
por: Lee, Yong-ho, et al.
Publicado: (2019)

Based on network pharmacology method to discovered the targets and therapeutic mechanism of Paederia scandens against nonalcoholic fatty liver disease in chicken
por: Wu, Qiang, et al.
Publicado: (2021)

Corrigendum: Genistein Improves Liver Damage in Male Mice Exposed to Morphine
Publicado: (2018)

Efficacy and Safety of Empagliflozin on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Zhang, Yuyuan, et al.
Publicado: (2022)

Corrigendum: Chronic Hepatitis B Infection with Low Level Viremia Correlates with the Progression of the Liver Disease
Publicado: (2022)

Corrigendum to “Transmission Model of Hepatitis B Virus with the Migration Effect”
por: Khan, Muhammad Altaf, et al.
Publicado: (2016)

Corrigendum to “Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway” [Redox Biol. 52 (2022) 102288]
por: Cai, Chen, et al.
Publicado: (2023)

Daclatasvir: potential role in hepatitis C [Corrigendum]
Publicado: (2014)

Corrigendum to “Spontaneous Resolution of Symptomatic Hepatic Sarcoidosis”
por: Nguyen, Viva, et al.
Publicado: (2018)

Corrigendum to “The Effect of Rice Bran Extract on Arterial Blood Pressure, Hepatic Steatosis, and Inflammation in Mice Fed with a High-Fat Diet”
por: Duansak, Naphatsanan, et al.
Publicado: (2020)

Corrigendum to “Effects of Electroacupuncture on Methamphetamine-Induced Behavioral Changes in Mice”
por: Ho, Tsung-Jung, et al.
Publicado: (2018)

Corrigendum to “Metabolic Syndrome, Inflammation, and Cancer”
por: Wu, Yong, et al.
Publicado: (2017)

Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study [Corrigendum]
Publicado: (2013)

Corrigendum to “Acute-on-Chronic Liver Failure in Pregnant Patients with Chronic Hepatitis B: A Retrospective Observational Case Series Study”
por: Wang, Shiwei, et al.
Publicado: (2020)

Hepatic transcriptome signatures in mice and humans with nonalcoholic fatty liver disease
por: Ding, Yiming, et al.
Publicado: (2023)

Corrigendum to “Inflammatory Effects of Subacute Exposure of Roundup in Rat Liver and Adipose Tissue”
Publicado: (2020)

Corrigendum: The Microbiota and It’s Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease
por: Gu, Congwei, et al.
Publicado: (2022)

Differential role of MLKL in alcohol-associated and non–alcohol-associated fatty liver diseases in mice and humans
por: Miyata, Tatsunori, et al.
Publicado: (2022)

Corrigendum to “Reduced Oxidative Stress Contributes to the Lipid Lowering Effects of Isoquercitrin in Free Fatty Acids Induced Hepatocytes”
por: Hassan, Waseem, et al.
Publicado: (2015)

Corrigendum to “Beta-Arrestin 1 Mediates Liver Thyrotropin Regulation of Cholesterol Conversion Metabolism via the Akt-Dependent Pathway”
por: Niu, Shaona, et al.
Publicado: (2018)

Corrigendum to “Chronic Glucocorticoid-Rich Milieu and Liver Dysfunction”
por: Villagarcía, Hernán Gonzalo, et al.
Publicado: (2018)

Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway [Corrigendum]
por: Mu, Mao, et al.
Publicado: (2019)

Corrigendum to “Osteocalcin is necessary and sufficient to maintain muscle mass in older mice” [Mol Metabol 5 (2017) 1042–1047]
por: Mera, Paula, et al.
Publicado: (2017)

Corrigendum to ‘ABHD15 regulates adipose tissue lipolysis and hepatic lipid accumulation’ [Molecular Metabolism 25 (2019) p.83–94]
por: Stöckli, Jacqueline, et al.
Publicado: (2021)

Corrigendum to “Immunocompetent Mice Model for Dengue Virus Infection”
por: Gonçalves, Denise, et al.
Publicado: (2018)

Hepatic Innervations and Nonalcoholic Fatty Liver Disease
por: Adori, Monika, et al.
Publicado: (2023)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Corrigendum: Magnetic Resonance Elastography and Diffusion Weighted Imaging in the Evaluation of Hepatic Fibrosis in Chronic Hepatitis B
por: Hennedige, Tiffany P., et al.
Publicado: (2020)

Corrigendum to “An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients”
por: Enomoto, Hirayuki, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bjuu8hafqrjtsenigqtcp87t5o